Home › Metastatic Cancer › Missouri › O'Fallon
Metastatic Cancer clinical trials in O'Fallon, MO
3 studies for Metastatic Cancer are looking for participants at sites in and around O'Fallon (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters · 4 mi away
- Saint Luke's Hospital, Chesterfield · 12 mi away
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Siteman Cancer Center - St. Peters, City of Saint Peters · 4 mi away
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
RecruitingPhase 2
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters · 4 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in O'Fallon
- Obesity11 studies
- Overweight10 studies
- Major Depressive Disorder9 studies
- Prostate Cancer9 studies
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer7 studies
- Acute Myeloid Leukemia6 studies
- Breast Cancer6 studies
- Depression5 studies
- Colorectal Cancer5 studies
- Melanoma5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.